loadpatents
name:-0.024821996688843
name:-0.022669076919556
name:-0.0051450729370117
Witztum; Joseph L. Patent Filings

Witztum; Joseph L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Witztum; Joseph L..The latest application filed is for "modulation of apolipoprotein c-iii (apociii) expression in lipoprotein lipase deficient (lpld) populations".

Company Profile
4.20.22
  • Witztum; Joseph L. - San Diego CA
  • Witztum; Joseph L. - Sand Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modulation Of Apolipoprotein C-iii (apociii) Expression In Lipoprotein Lipase Deficient (lpld) Populations
App 20220213472 - Alexander; Veronica J. ;   et al.
2022-07-07
Compositions And Methods For Diagnosis Of Cardiovascular Disease
App 20210388116 - Miller; Yury ;   et al.
2021-12-16
Inhibition Of Oxidation-specific Epitopes To Treat Ischemic Reperfusion Injury
App 20210221916 - Tsimikas; Sotirios ;   et al.
2021-07-22
Therapies And Methods To Treat Tlr2-mediated Diseases And Disorders
App 20210155679 - Witztum; Joseph L. ;   et al.
2021-05-27
Antibodies to oxidized phospholipids
Grant 11,008,381 - Witztum , et al. May 18, 2
2021-05-18
Antibodies to oxidized phospholipids
Grant 11,008,382 - Witztum , et al. May 18, 2
2021-05-18
Modulation Of Apolipoprotein C-iii (apociii) Expression In Lipoprotein Lipase Deficient (lpld) Populations
App 20200017854 - Alexander; Veronica J. ;   et al.
2020-01-16
Antibodies To Oxidized Phospholipids
App 20180334498 - Witztum; Joseph L. ;   et al.
2018-11-22
Antibodies To Oxidized Phospholipids
App 20180334497 - Witztum; Joseph L. ;   et al.
2018-11-22
Antibodies To Oxidized Phospholipids
App 20180265576 - Witztum; Joseph L. ;   et al.
2018-09-20
Modulation Of Apolipoprotein C-iii (apociii) Expression In Lipoprotein Lipase Deficient (lpld) Populations
App 20170233732 - Alexander; Veronica J. ;   et al.
2017-08-17
Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations
Grant 9,593,333 - Alexander , et al. March 14, 2
2017-03-14
Peptide-phospholipid conjugates
Grant 9,518,088 - Van Nieuwenhze , et al. December 13, 2
2016-12-13
Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (TIA) and peripheral arterial disease (PAD)
Grant 9,347,959 - Tsimikas , et al. May 24, 2
2016-05-24
Modulation Of Apolipoprotein C-iii (apociii) Expression In Lipoprotein Lipase Deficient (lpld) Populations
App 20150376614 - Alexander; Veronica J. ;   et al.
2015-12-31
Antibodies To Oxidized Phospholipids
App 20150376268 - Witztum; Joseph L. ;   et al.
2015-12-31
Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
Grant 9,075,050 - Tsimikas , et al. July 7, 2
2015-07-07
Oxidative Biomarkers In Predicting Risk Of Stroke, Transient Ischemic Attack (tia) And Peripheral Arterial Disease (pad)
App 20150185239 - Tsimikas; Sotirios ;   et al.
2015-07-02
Peptide Mimotopes To Oxidation Specific Epitopes
App 20150056209 - Witztum; Joseph L. ;   et al.
2015-02-26
Methods to determine atherosclerosis regression, plaque stabilization and cardiovascular risk
Grant 8,883,428 - Witztum , et al. November 11, 2
2014-11-11
Methods For Assessing Atherogenesis By Determining Oxidized Phospholipid To Apolipoprotein B Ratios
App 20140309124 - Tsimikas; Sotirios ;   et al.
2014-10-16
Peptide-phospholipid Conjugates
App 20130345117 - Van Nieuwenhze; Michael S. ;   et al.
2013-12-26
Methods For Assessing Atherogenesis By Determining Oxidized Phospholipid To Apolipoprotein B Ratios
App 20120149596 - Tsimikas; Sotirios ;   et al.
2012-06-14
Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
Grant 8,129,123 - Tsimikas , et al. March 6, 2
2012-03-06
Methods To Determine Atherosclerosis Regression, Plaque Stabiliztion And Cardiovascular Risk
App 20120035074 - Witztum; Joseph L. ;   et al.
2012-02-09
Reagents for diagnosing, imaging and treating atherosclerotic disease
Grant 7,575,873 - Witztum , et al. August 18, 2
2009-08-18
Methods for diagnosing, imaging and treating atherosclerotic disease
Grant 7,556,927 - Witztum , et al. July 7, 2
2009-07-07
Methods and compositions for treating atherosclerosis
App 20070122419 - Witztum; Joseph L. ;   et al.
2007-05-31
Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios
App 20060177435 - Tsimikas; Sotirios ;   et al.
2006-08-10
Reagents for diagnosing, imaging and treating atherosclerotic disease
App 20040120893 - Witztum, Joseph L. ;   et al.
2004-06-24
Methods for diagnosing, imaging and treating atherosclerotic disease
App 20040071632 - Witztum, Joseph L. ;   et al.
2004-04-15
Reagents and methods for diagnosing, imaging and treating atherosclerotic disease
Grant 6,716,410 - Witztum , et al. April 6, 2
2004-04-06
Methods and reagents for non-invasive imaging of atherosclerotic plaque
Grant 6,375,925 - Tsimikas , et al. April 23, 2
2002-04-23
DNA encoding recombinant lipoprotein antigens
Grant 5,786,206 - Smith , et al. July 28, 1
1998-07-28
Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas
Grant 5,460,947 - Young , et al. October 24, 1
1995-10-24
Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
Grant 5,408,038 - Smith , et al. April 18, 1
1995-04-18
Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas
Grant 5,330,910 - Young , et al. * July 19, 1
1994-07-19
Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample
Grant 4,828,986 - Smith , et al. May 9, 1
1989-05-09
Receptors specific for hapten-modified self proteins
Grant 4,778,752 - Curtiss , et al. October 18, 1
1988-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed